𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells

✍ Scribed by P. Limtrakul; S. Siwanon; S. Yodkeeree; C. Duangrat

Book ID
113848139
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
351 KB
Volume
14
Category
Article
ISSN
0944-7113

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of BCRP/MXR, MRP1 and MDR1/P-Glyc
Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells
✍ Ulrike Stein; Hermann Lage; Andreas Jordan; Wolfgang Walther; Susan E. Bates; Th πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 234 KB

## Abstract The impact of the ABC transporters breast cancer resistance protein/mitoxantrone resistance associated transporter (BCRP/MXR), multidrug resistance‐associated protein 1 (MRP1) and multidrug resistance gene‐1/P‐glycoprotein (__MDR1__/PGP) on the multidrug resistance (MDR) phenotype in ch

Functional expression of p-glycoprotein
Functional expression of p-glycoprotein and multidrug resistance-associated protein (mrp1) in primary cultures of rat astrocytes
✍ X. DeclΓ¨ves; A. Regina; J.-L. Laplanche; F. Roux; B. Boval; J.-M. Launay; J.-M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 2 views

Although it has been well established that the drug efflux pump P-glycoprotein (P-gp) protects the brain against the entry of cytotoxic drugs, its real in situ localization, i.e., at brain capillary endothelial cells or on astrocyte foot processes, is still controversial. The aim of this study was t

The effects of cannabinoids on P-glycopr
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells
✍ M.L. Holland; J.A. Panetta; J.M. Hoskins; M. Bebawy; B.D. Roufogalis; J.D. Allen πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 229 KB

Cannabis is the most widely used illicit drug in the world. Cannabinoids are used therapeutically by some patients as they have analgesic, anti-emetic and appetite stimulant properties which palliate adverse symptoms. Use of these agents in an oncology setting raises the question of whether they act